Psychosis breakthrough on antipsychotic maintenance medication (BAMM): what can we learn?
Author:
Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health
Link
http://www.nature.com/articles/s41537-017-0039-z.pdf
Reference15 articles.
1. Leucht, S. et al. Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis. Lancet. 379, 2063–2071 (2012).
2. Alvarez-Jimenez, M. et al. Risk factors for relapse following treatment for first episode psychosis: a systematic review and meta-analysis of longitudinal studies. Schizophr. Res. 139, 116–128 (2012).
3. Kane, J. M., Kishimoto, T. & Correll, C. U. Non-adherence to medication in patients with psychotic disorders: epidemiology, contributing factors and management strategies. World Psychiatr. 12, 216–226 (2013).
4. Lopez, L. V. et al. Accuracy of clinician assessments of medication status in the emergency setting: a comparison of clinician assessment of antipsychotic usage and plasma level determination. J. Clin. Psychopharmacol. 37, 310–314 (2017).
5. Alphs, L. et al. Factors associated with relapse in schizophrenia despite adherence to long-acting injectable antipsychotic therapy. Int. Clin. Psychopharmacol. 31, 202–209 (2016).
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A case of posterior cortical atrophy and paranoid schizophrenia;Progress in Neurology and Psychiatry;2024-01
2. Breakthrough Psychosis and Long-Acting Injectable Antipsychotics;Korean Journal of Schizophrenia Research;2023-04-30
3. Second-Generation Antipsychotic Long-Acting Injection Reduced the Time of Restrictive Interventions in Patients With Schizophrenia;Journal of Clinical Psychopharmacology;2022-09-03
4. The pharmacological treatment of schizophrenia: How far have we come?;Psychiatry and Clinical Neurosciences Reports;2022-05-30
5. Striatal functional connectivity in psychosis relapse: A hypothesis generating study;Schizophrenia Research;2021-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3